be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Final Report - analytica closes with record-breaking visitor attendance
The 26th analytica m...
MINICUBE PCR A NEW TOOL FOR GENETIC RESEARCH
The importance of research in our genes cannot ...
Bioeconomy drives Lodzkie. Americans are looking up to us
Close to a thousand participants, ...
Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidate
Pharnext Announces Positive Topline Results from Pivotal Phase 3 Trial of PXT3003 for Treatment of Charcot-Marie-Tooth Type 1A Disease

All articles

Filters:

Show search box

2015-08-12

Mutations in a cell line stops stem-cell trial to cure blindness

Mutations in a cell line stops stem-cell trial to cure blindness

Induced pluripotent stem cells (iPSC) turned into specialized retinal cells were meant to cure the damage caused by age-related macular degeneration leading to blindness. The trial was halted due to mutations identified in cells of a second patient.... Read more

Tags clinical trials , stem cells , mutations , macular degeneration , blindness , iPSC

2015-04-02

East London genomic study of Asians will shed light on new drugs design

East London genomic study of Asians will shed light on new drugs design

East London Genes and Health project, assuming sequencing genomes of 100 000 Pakistanis and Bangladeshis, has been launched on March 12, 2015. Comparing to people of European ancestry, these ethnic groups more often suffer from various illnesses, mainly heart diseases and type II diabetes. The projec... Read more

Tags mutations , genome sequencing , East London Genes and Health